UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5874-5880

2011

Volltextzugriff (PDF)

Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease

Clinical pharmacokinetics, 2021-03, Vol.60 (3), p.391-401

2021

Volltextzugriff (PDF)

LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease

Movement disorders, 2023-03, Vol.38 (3), p.386-398

2023

Volltextzugriff (PDF)

Revefenacin Absorption, Metabolism, and Excretion in Healthy Subjects and Pharmacological Activity of Its Major Metabolite

Drug metabolism and disposition, 2020-12, Vol.48 (12), p.1312-1320

2020

Volltextzugriff (PDF)

The metabolic fate of izencitinib, a gut-selective pan-JAK inhibitor, in humans. Identification of unusual fecal metabolites and implications for MIST evaluation

Medicinal chemistry research, 2023-09, Vol.32 (9), p.2071-2088

2023

Volltextzugriff (PDF)

Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function

International journal of chronic obstructive pulmonary disease, 2019-10, Vol.14, p.2305-2318

2019

Volltextzugriff (PDF)

Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects

British journal of clinical pharmacology, 2012-11, Vol.74 (5), p.788-796

2012

Volltextzugriff (PDF)

Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study

Clinical pharmacology in drug development, 2020-01, Vol.9 (1), p.130-139

2020

Volltextzugriff (PDF)

Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancer

Cancer chemotherapy and pharmacology, 2015-02, Vol.75 (2), p.401-410

2015

Volltextzugriff (PDF)

A review of the pharmacokinetics of cefpodoxime proxetil

Drugs (New York, N.Y.), 1991, Vol.42 (Supplement 3), p.13-21

BORIN, M. T

1991

Volltextzugriff (PDF)

Systemic Absorption of Clindamycin after Intravaginal Administration of Clindamycin Phosphate Ovule or Cream

Journal of clinical pharmacology, 1999-08, Vol.39 (8), p.805-810

1999

Volltextzugriff (PDF)

Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients

Antiviral research, 1997-06, Vol.35 (1), p.53-63

1997

Volltextzugriff (PDF)

Cefpodoxime pharmacokinetics in children: effect of food

The Pediatric infectious disease journal, 1998-09, Vol.17 (9), p.799-804

1998

Volltextzugriff (PDF)

Pharmacokinetics of Cefpodoxime Proxetil in Healthy Young and Elderly Volunteers

Journal of clinical pharmacology, 1994-07, Vol.34 (7), p.774-781

1994

Volltextzugriff (PDF)

Effect of Timing of Food on Absorption of Cefpodoxime Proxetil

Journal of clinical pharmacology, 1995-05, Vol.35 (5), p.505-509

1995

Volltextzugriff (PDF)

Pharmacokinetic and Tolerance Studies of Cefpodoxime after Single- and Multiple-Dose Oral Administration of Cefpodoxime Proxetil

Journal of clinical pharmacology, 1991-12, Vol.31 (12), p.1137-1145

1991

Volltextzugriff (PDF)

Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate

Clinical pharmacology and therapeutics, 1997-05, Vol.61 (5), p.544-553

1997

Volltextzugriff (PDF)

Systemic Absorption of Clindamycin Following Intra vaginal Application of Clindamycin Phosphate 1% Cream

Journal of clinical pharmacology, 1990-01, Vol.30 (1), p.33-38

Borin, Marie T.

1990

Volltextzugriff (PDF)

Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients

Antimicrobial Agents and Chemotherapy, 1997-09, Vol.41 (9), p.1892-1897

1997

Volltextzugriff (PDF)

In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylate

Pharmaceutical research, 1991-12, Vol.8 (12), p.1482-1488

1991

Volltextzugriff (PDF)

Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections

Antimicrobial Agents and Chemotherapy, 1996-03, Vol.40 (3), p.767-771

1996

Volltextzugriff (PDF)

Single dose bioavailability of acetaminophen following oral administration

International journal of pharmaceutics, 1989-09, Vol.54 (3), p.199-209

1989

Volltextzugriff (PDF)

Species-dependent enantioselective pharmacokinetics of PNU-103017, a Pyrone HIV protease inhibitor

Chirality (New York, N.Y.), 1998, Vol.10 (3), p.210-216

1998

Volltextzugriff (PDF)

The effect of food on gastrointestinal (GI) transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy

Pharmaceutical research, 1990-03, Vol.7 (3), p.304-307

1990

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(46)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Humans
(28)
Pharmacology & Pharmacy
(25)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Pharmacology. Drug Treatments
(22)
Adult
(21)
Male
(19)
Middle Aged
(16)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(15)
Female
(15)
Antibacterial Agents
(10)
Adolescent
(9)
Aids/hiv
(8)
Pharmacokinetics
(8)
Aged
(7)
Ceftizoxime - Analogs & Derivatives
(7)
Ceftizoxime - Pharmacokinetics
(7)
Half-Life
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease

LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease

Revefenacin Absorption, Metabolism, and Excretion in Healthy Subjects and Pharmacological Activity of Its Major Metabolite

The metabolic fate of izencitinib, a gut-selective pan-JAK inhibitor, in humans. Identification of unusual fecal metabolites and implications for MIST evaluation

Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function

Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects

Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study

Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancer

A review of the pharmacokinetics of cefpodoxime proxetil

Systemic Absorption of Clindamycin after Intravaginal Administration of Clindamycin Phosphate Ovule or Cream

Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients

Cefpodoxime pharmacokinetics in children: effect of food

Pharmacokinetics of Cefpodoxime Proxetil in Healthy Young and Elderly Volunteers

Effect of Timing of Food on Absorption of Cefpodoxime Proxetil

Pharmacokinetic and Tolerance Studies of Cefpodoxime after Single- and Multiple-Dose Oral Administration of Cefpodoxime Proxetil

Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate

Systemic Absorption of Clindamycin Following Intra vaginal Application of Clindamycin Phosphate 1% Cream

Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients

In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylate

Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections

Single dose bioavailability of acetaminophen following oral administration

Species-dependent enantioselective pharmacokinetics of PNU-103017, a Pyrone HIV protease inhibitor

The effect of food on gastrointestinal (GI) transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy

Suchergebnisse filtern